Reduced tumour burden in Acly-KO and EVT0185-treated mice was accompanied by lower Ki67 and higher cleaved caspase 3 levels at the tumour edge (Extended Data Fig. 10a–f). This evidence concerns the gene ACLY and neoplasm.